Intracranial Arteriovenous Malformations
11
3
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
9%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (11)
PHIL® Embolic System Pediatric IDE
Hereditary Hemorrhagic Telangiectasia and Neurovascular Manifestations, in the Danish HHT Database
Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations
Comparison of Imaging Quality Between Spectral Photon Counting Computed Tomography (SPCCT) and Dual Energy Computed Tomography (DECT)
Safety and Feasibility of the Infinity Catheter for Radial Access
Non-adhesive Liquid Embolic System in the Embolization of Cerebral Arteriovenous Malformations
MRI for the Early Evaluation of Acute Intracerebral Hemorrhage
Surgical Management of Cerebral Arteriovenous Malformations Within Hybrid Operation Room
Multimodal Imaging Techniques in Assessing the Surgical Risk for Eloquent Arteriovenous Malformations
Nationwide Treatment Survey of Intracranial Arteriovenous Malformation in China
Functional Magnetic Resonance Imagine(fMRI)Navigation in Intracranial Arteriovenous Malformation Surgery